Xenon Pharmaceuticals Inc. (XENE) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$7.5M

Net Income/Loss (FY2025)

-$345.9M

Total Assets (FY2025)

$633.2M

Total Equity (FY2025)

$581.8M

Cash Flows from Operating Activities (FY2025)

-$279.1M

Source: Xenon Pharmaceuticals Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.